Replies to post #77547 on Ayala Pharmaceuticals Inc (ADXS)

[ubmmg]

Let me start a speculation: Chinese deal is coming!

[Chemist823]

"...12-month overall survival rate was 38%, exceeding the pre-set benchmark by more than 50%. In the subgroup carrying HPV16, the survival rate was 44%, and in the subgroup carrying HPV18, the survival rate was 41%"
Impressive considering the patients had already been heavily pre-treated and were at the end of the line. I'm a little surprised the EMA stated that they would probably need more data to approve although it was a small study.